Arrakis Therapeutics
Latest round
- Series B
Last raised
- Apr 2019
Total raised
- $28M
Investors
- 14
About Arrakis Therapeutics
Arrakis Therapeutics, Inc.Founded in 2015 and headquartered in Waltham, Massachusetts, Arrakis Therapeutics, Inc. is dedicated to the development of RNA-targeted small-molecule (rSM) therapies.00 mn.Arrakis Therapeutics specializes in developing RNA-targeted small-molecule (rSM) medicines, a new class of genetic therapies aimed at treating various diseases. Their proprietary and partnered rSM medicines are designed to bind to RNA using small molecules, enabling the creation of oral medications for conditions such as myotonic dystrophy.Arrakis Therapeutics generates revenue through strategic partnerships and collaborations within the biopharmaceutical industry, focusing on B2B relationships with pharmaceutical companies and research organizations.00 mn to advance its pipeline of novel RNA-targeted small molecules and reach clinical testing with one or more candidates. The company is targeting expansion into new geographic markets, with specific efforts aimed at increasing their presence in Europe and Asia by 2022. This strategy aligns with their goal of broadening access to their innovative therapies across multiple regions.
Who invested in Arrakis Therapeutics
14 investors across 2 rounds
See all investors in Arrakis Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Arrakis Therapeutics
Who invested in Arrakis Therapeutics?
Arrakis Therapeutics has 14 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Arrakis Therapeutics raised?
Arrakis Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Arrakis Therapeutics last raise money?
Arrakis Therapeutics's most recent round on record is a Series B, in Apr 2019.
What does Arrakis Therapeutics do?
Arrakis Therapeutics is a pharmaceuticals company.
Where is Arrakis Therapeutics headquartered?
Arrakis Therapeutics is headquartered in Waltham, US.
Which VCs invest in companies like Arrakis Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Arrakis Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Arrakis Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.